AXCELIS TECHNOLOGIES INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No SEC Form 4 filings for $ACLS in the last 30 days.
See all $ACLS insider activity →Axcelis (ACLS) plans to build a 200,000 sq. ft. manufacturing facility in Pyeongtaek, Korea, with production starting in late 2028. The company's CEO and local officials celebrated the groundbreaking, highlighting its significance for Axcelis' growth and the semiconductor industry.
Zacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.
Axcelis Technologies (ACLS) reported $839M revenue in 2025, with $570M in cash and minimal debt. It announced a $35M investment in a new ion implantation factory in Korea, expected to start production in late 2028. Q2 2026 revenue rose, but EPS fell to $0.75 from $0.98, with gross margin slipping to 42.4%. The company expects revenue growth in 2026-2027, guided at $230M for Q3. Hedge funds increased holdings, while short interest remains at 6.70%.
Over the past 7 days, AlphAI's AI scored 3 news stories mentioning ACLS (AXCELIS TECHNOLOGIES INC). Coverage has skewed bullish: 1 bullish, 2 neutral, and 0 bearish.
Recent ACLS coverage spans financial news, technology and market movers.
The new plant expands Axcelis' production capacity and signals long‑term growth, but the impact on near‑term price is limited.
Positive sector tailwinds may lift the stock.
The capital spend and margin pressure create short‑term downside risk, while the long‑term capacity expansion and pending Veeco merger offer upside.
The capex announcement raises near‑term cost concerns and execution risk, pressuring the share price.
Minor insider tax withholding; unlikely to affect share price materially.
AlphAI scores every news story that mentions ACLS with an AI model for sentiment and relevance, and aggregates insider trades from AXCELIS TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Axcelis (ACLS) plans to build a 200,000 sq. ft. manufacturing facility in Pyeongtaek, Korea, with production starting in late 2028. The company's CEO and local officials celebrated the groundbreaking, highlighting its significance for Axcelis' growth and the semiconductor industry.
1 min readZacks Research Daily features reports on Cisco (CSCO), Shopify (SHOP), and Starbucks (SBUX). Cisco's shares outperformed its industry, driven by demand in networking, security, and AI infrastructure. Shopify's growth is supported by merchant gains and AI tools, despite competition. Starbucks benefits from improving customer traffic and expanding margins, though restructuring costs are a concern.
3 min readAxcelis Technologies (ACLS) reported $839M revenue in 2025, with $570M in cash and minimal debt. It announced a $35M investment in a new ion implantation factory in Korea, expected to start production in late 2028. Q2 2026 revenue rose, but EPS fell to $0.75 from $0.98, with gross margin slipping to 42.4%. The company expects revenue growth in 2026-2027, guided at $230M for Q3. Hedge funds increased holdings, while short interest remains at 6.70%.
3 min readAxcelis Technologies (ACLS) shares fell despite announcing a $35M investment in a new South Korea plant to boost ion implantation capacity. Investors are concerned about higher spending and execution risks. The company's strong balance sheet may support long-term growth, but profitability has declined, making it more vulnerable to semiconductor cycle fluctuations.
2 min readAxcelis Technologies (ACLS) EVP Christopher Tatnall had 136 shares withheld to pay taxes on RSU vesting, valued at $105.04 per share. He retains 27,491 shares, including 20,590 unvested shares subject to forfeiture. The RSUs were granted in 2023 under the 2012 Equity Incentive Plan.
2 min readAxcelis Technologies (ACLS) shares fell 22.4% over the past month despite Q2 revenue growth of 10.6% and improved bookings. Margins declined, and backlog remains weak. Management expects mid-single-digit revenue growth in 2026. Memory and power demand show recovery potential, but customer concentration and China exposure add volatility.
3 min readAxcelis Technologies (ACLS) plans to invest $35M in a new facility in South Korea to expand manufacturing. The move aims to improve customer responsiveness and add capacity near Asian chipmakers. South Korea contributed 26% of Q2 revenues. ACLS reported Q2 bookings up 36.1% YoY, but backlog and margins declined. The company has $577M in liquidity to support investments.
2 min readAxcelis Technologies (ACLS) expects mid-single-digit revenue growth in 2026 and 2027, with 2027 estimates at $981M and EPS of $5.29. Aftermarket revenue grew 35% YoY, but margins fell. ACLS trades at a premium valuation, with a forward P/E of 21.2X. A merger with Veeco Instruments is pending regulatory approval.
2 min readAxcelis Technologies (ACLS) is investing $35M in a new Korea facility. Its stock has fallen 25.1% in the past month, but is up 22.0% YTD and 119.5% over 5 years. Analysts debate its valuation, with a fair value estimate of $161 vs. a recent close of $105.04, citing growth potential in silicon carbide (SiC) demand.
2 min readAxcelis Technologies (Nasdaq: ACLS) plans to invest $35 million in a new ion implantation equipment manufacturing facility in Pyeongtaek, South Korea. The 200,000 sq. ft. plant will include cleanrooms and a training center, aiming to support global semiconductor demand. Production is set to begin in late 2028, according to the company.
1 min read
